ESC Professional Premium Access

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab decreases myocardial inflammation in individuals with acute coronary syndrome (ACS)

Congress Presentation

About the speaker

Doctor Efthymios Ziogos

The Johns Hopkins University School of Medicine, Baltimore (United States of America)
0 follower

4 more presentations in this session

Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients

Speaker: Doctor C. Materne (Paris, FR)

Thumbnail

Analysis of immune infiltration and cuproptosis-related genes in acute myocardial infarction

Speaker: Doctor Y. Xiao (Changsha, CN)

Thumbnail

Impact of nutritional status and systemic immune-inflammation index on mortality in patients with acute myocardial infarction

Speaker: Doctor H. Kwak (Daegu, KR)

Thumbnail

Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction

Speaker: Doctor S. Cederstrom (Stockholm, SE)

Thumbnail

Access the full session

Markers of inflammation and outcomes in patients with acute coronary syndromes

Speakers: Doctor E. Ziogos, Doctor C. Materne, Doctor Y. Xiao, Doctor H. Kwak, Doctor S. Cederstrom
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations